Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MLH1 mutation
i
Other names:
MLH1, COCA2, FCC2, HNPCC, HNPCC2, MutL homolog 1
Associations
(6)
News
Trials
C2 | Sensitive
C3 | Sensitive
C4 | Sensitive
C2 | Resistant
C3 | Resistant
C4 | Resistant
Show legend
Drug categories
Immune Checkpoint Inhibitors
Immunotherapy
CD Protein Inhibitors
PARP Inhibitors
Tyrosine Kinase Inhibitors
Cancel
Gastric Cancer
Urothelial Cancer
Prostate Cancer
HER2 Positive Breast Cancer
tremelimumab
C2
MLH1 mutation
|
Gastric Cancer
|
tremelimumab
durvalumab + tremelimumab
C2
MLH1 mutation
|
Gastric Cancer
|
durvalumab + tremelimumab
olaparib
C2
MLH1 mutation
|
Prostate Cancer
|
olaparib
pembrolizumab
C4
MLH1 mutation
|
Urothelial Cancer
|
pembrolizumab
nivolumab + ipilimumab
C4
MLH1 mutation
|
Urothelial Cancer
|
nivolumab + ipilimumab
trastuzumab
C3
MLH1 mutation
|
HER2 Positive Breast Cancer
|
trastuzumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
